Browse > Article
http://dx.doi.org/10.3746/jfn.2010.15.1.014

Anti-inflammatory Activity of Stevia rebaudiana in LPS-induced RAW 264.7 Cells  

Jeong, Il-Yun (Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute)
Lee, Hyo-Jung (Department of Life Science, Gwangju Institute of Science and Technology)
Jin, Chang-Hyun (Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute)
Park, Yong-Dae (Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute)
Choi, Dae-Seong (Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute)
Kang, Min-Ah (AI Control Material Research Center, Korea Research Institute of Bioscience and Biotechnology)
Publication Information
Preventive Nutrition and Food Science / v.15, no.1, 2010 , pp. 14-18 More about this Journal
Abstract
Stevia rebaudiana (SR) is an herb used traditionally as a sweetener in Paraguay and Brazil, whose use is spreading to other countries, such as Japan, Korea and China. In addition to its low calorie sweet taste, SR appears to have other beneficial properties, such as hypotensive capabilities and inflammation reduction. To identify the bioactive natural constituents exerting anti-inflammatory activities, we examined the EtOAc fraction of SR. In the inflammatory mediator inhibitory assay from lipopolysaccharide (LPS)-activated macrophages, the EtOAc fraction significantly, and dose dependently, inhibited the enhanced production of nitric oxide (NO) and inducible nitric oxide synthase (iNOS) expression. We also found that treatment of cells with the EtOAc fraction significantly inhibited LPS-stimulated nuclear factor-${\kappa}B$ (NF-${\kappa}B$) reporter gene expression. Such inhibition of NF-${\kappa}B$ was closely associated with the inhibition of interleukin-6 (IL-6) and the monocyte chemoattractant protein-1 (MCP-1). Therefore, we suggest that SR has the potential for development as a functional food for the treatment of immune diseases, such as rheumatoid arthritis and lupus.
Keywords
Stevia rebaudiana; lipopolysaccharide; nitric oxide; inducible nitric oxide synthase; nuclear factor kappa B;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Boonkaewwan C, Ao M, Toskulkao C, Rao MC. 2008. Specific immunomodulatory and secretory activities of stevioside and steviol in intestinal cells. J Agric Food Chem 56: 3777-3784.   DOI   ScienceOn
2 Nathan C. 1992. Nitric oxide: discovery and impact on clinical medicine. FASEB J 92: 164-169.
3 Szekancecz Z, Koch E. 2007. Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol 19: 289-295.   DOI   ScienceOn
4 Bosca L, Zeini M, Traves G, Hortelano S. 2005. Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate. Toxicology 208: 249-258.   DOI   ScienceOn
5 Mormann M, Thederan M, Nackchbandi I. 2008. Lipopolysaccharides (LPS) induce the differentiation of human monocytes to osteoclasts in a tumour necrosis factor (TNF) alpha-dependent manner: a link between infection and pathological bone resorption. Mol Immunol 45: 3330-3337.   DOI   ScienceOn
6 Baeuerle A, Henkel T. 1994. Function and activation of NF-$\kappa$B in the immune system. Annu Rev Immunol 12: 141-179.   DOI   ScienceOn
7 Baldwin R. 1996. The NF-$\kappa$B and I$\kappa$B Proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683.   DOI   ScienceOn
8 Jeppesen PB, Gregersen S, Alstrup KK, Hermansen K. 2002. Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: studies in the diabetic Goto-Kakizaki (GK) rats. Phytomedicine 9: 9-14.   DOI   ScienceOn
9 Ghanta S, Banerjee A, Poddar A, Chattopadhyay S. 2007. Oxidative DNA damage preventive activity and antioxidant potential of Stevia rebaudiana (Bertoni) Bertoni, a natural sweetener. J Agric Food Chem 55: 10962-10967.   DOI   ScienceOn
10 Chaiwat B, Chaivat T, Molvibha V. 2006. Anti-inflammatory and immunomodulatory activities of stevioside and its metabolite steviol on THP-1 cells. J Agric Food Chem 54: 785-789.   DOI   ScienceOn
11 Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow condition. Nature 398: 718-723.   DOI   ScienceOn
12 Charo IF, Taubman MB. 2004. Chemokines in the pathogenesis of vascular disease. Circ Res 95: 858-866.   DOI   ScienceOn
13 Sun Z, Andersson R. 2002. NF-kappaB activation and inhibition: a review. Shock 18: 99-106.   DOI   ScienceOn
14 Chan P, Tomlinson B, Chen Y, Liu J, Hsieh M, Cheng J. 2002. A double-blind placebo controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. Clin Pharmacol 50: 215-220.
15 Clancy RM, Amin AR. 1998. The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41: 1141-1151.   DOI   ScienceOn
16 Salas M, Gironella M, Salasa M. 2002. Nitric oxide supplementation ameliorates dextran sulfate sodium-induced colitis in mice. Lab Invest 82: 597-607.   DOI   ScienceOn